{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:14:21Z","timestamp":1746677661095,"version":"3.40.5"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Background\/Purpose:<\/jats:title>\n            <jats:p>To report a case of acute recurrent central serous chorioretinopathy that developed after a regimen of corticosteroid enemas and suppositories.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Observational case report. Fluorescein angiography and spectral domain optical coherence tomography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A 47-year-old male patient with ulcerative colitis managed through hydrocortisone enemas presented to clinic with a 1-day history of blurry vision of his left eye. Posterior segment examination revealed subretinal fluid in the superotemporal macula of the left eye extending centrally. After diagnosis of acute central serous chorioretinopathy, the patient was advised to taper steroid enemas and his visual symptoms and subretinal fluid resolved within the month. Seven years later, several months after using steroid suppositories for the first time since the original central serous chorioretinopathy episode, asymptomatic subretinal fluid accumulation with foveal sparing was found on routine ophthalmic examination. Three months later, most of this fluid had resolved with minimal residual subretinal fluid on clinical examination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Acute central serous chorioretinopathy may develop after corticosteroid enema or suppository use, a route of administration that has not been previously reported in association with the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0000000000000745","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T04:59:11Z","timestamp":1533099551000},"page":"15-17","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH STEROID ENEMA"],"prefix":"10.1097","volume":"15","author":[{"given":"Timothy J.","family":"Peiris","sequence":"first","affiliation":[{"name":"Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala E.","family":"El Rami","sequence":"additional","affiliation":[{"name":"Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Sun","sequence":"additional","affiliation":[{"name":"Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts; and"},{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: an update on pathogenesis and treatment","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye (Lond)"},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.sjopt.2015.01.002","article-title":"Steroid-induced central serous chorioretinopathy in a patient with non-arteritic anterior ischemic optic neuropathy","volume":"29","author":"Alkin","year":"2015","journal-title":"Saudi J Ophthalmol"},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/1757-1626-1-428","article-title":"Sudden loss of visual acuity following intra-articular steroid injection in to the knee joint: a case report","volume":"1","author":"Balakrishnan","year":"2008","journal-title":"Cases J"},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0161-6420(97)30082-7","article-title":"Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids","volume":"104","author":"Haimovici","year":"1997","journal-title":"Ophthalmology"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archopht.122.5.784","article-title":"Central serous chorioretinopathy after local application of glucocorticoids for skin disorders","volume":"122","author":"Karadimas","year":"2004","journal-title":"Arch Ophthalomol"},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000360014","article-title":"Central serous chorioretinopathy","volume":"232","author":"Liegl","year":"2014","journal-title":"Ophthalmologica"},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/2008-322X.170352","article-title":"Central serous chorioretinopathy misdiagnosed as posterior uveitis and the vicious circle of corticosteroid therapy","volume":"10","author":"Papadia","year":"2015","journal-title":"J Ophthalmic Vis Res"},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/WCO.0000000000000284","article-title":"Corticosteroids and the retina: a role for the mineralocorticoid receptor","volume":"29","author":"Behar-Cohen","year":"2016","journal-title":"Curr Opin Neurol"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:15:07Z","timestamp":1746652507000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000000745","relation":{},"ISSN":["1935-1089"],"issn-type":[{"type":"print","value":"1935-1089"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}